Publications by authors named "Marisa C Hildebrand"

Objectives: The Ryan Program collaborates with OBGYN residency programs in the United States (U.S.) to ensure that abortion and contraception care are incorporated into resident curriculum as required.

View Article and Find Full Text PDF

Background: The etonogestrel contraceptive implant is currently approved by the United States Food and Drug Administration (FDA) for the prevention of pregnancy up to 3 years. However, studies that suggest efficacy up to 5 years. There is little information on the prevalence of extended use and the factors that influence clinicians in offering extended use.

View Article and Find Full Text PDF